United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 96,372 | 56,636 | 18,929 | 19,462 | 22,792 |
| Depreciation Amortization | 28,166 | 18,302 | 9,049 | 28,659 | 19,490 |
| Income taxes - deferred | 46,962 | 28,964 | 9,752 | -1,038 | 708 |
| Accounts receivable | -25,313 | -32,969 | -9,312 | -21,956 | -17,345 |
| Accounts payable and accrued liabilities | -7,451 | -9,329 | -11,629 | -3,645 | -2,723 |
| Other Working Capital | -42,169 | -48,622 | -24,879 | -51,290 | -38,088 |
| Other Operating Activity | 75,713 | 56,470 | 42,309 | 129,531 | 88,567 |
| Operating Cash Flow | $172,280 | $69,452 | $34,219 | $99,723 | $73,401 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -422,326 | -142,596 | -71,776 | -61,551 | -212,005 |
| PPE Investments | -13,199 | -9,117 | -6,362 | -95,400 | -73,893 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -3,378 |
| Sale Of Investment | 310,348 | 214,023 | 91,299 | N/A | 183,099 |
| Purchase Sale Intangibles | 0 | N/A | N/A | -3,568 | N/A |
| Other Investing Activity | -20,747 | -17,156 | -4,934 | -5,667 | 11,591 |
| Investing Cash Flow | $-145,924 | $45,154 | $8,227 | $-162,618 | $-94,586 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 64,425 | 54,600 | 36,327 | 32,071 | 23,036 |
| Other Financing Activity | 18,726 | 16,355 | 10,759 | 4,406 | 2,710 |
| Financing Cash Flow | $83,151 | $70,955 | $47,086 | $36,477 | $25,746 |
| Exchange Rate Effect | 327 | -504 | 72 | -2,682 | 489 |
| Beginning Cash Position | 100,352 | 100,352 | 100,352 | 129,452 | 129,452 |
| End Cash Position | 210,186 | 285,409 | 189,956 | 100,352 | 134,502 |
| Net Cash Flow | $109,834 | $185,057 | $89,604 | $-29,100 | $5,050 |
| Free Cash Flow | |||||
| Operating Cash Flow | 172,280 | 69,452 | 34,219 | 99,723 | 73,401 |
| Capital Expenditure | -13,199 | -9,117 | -6,362 | -95,400 | -73,893 |
| Free Cash Flow | 159,081 | 60,335 | 27,857 | 4,323 | -492 |